Clinical trials and practice PUBLISHERS OpenJournal ISSN 2771-7380 Role of Bactiguard Infection Technology in Preventing Catheter-Associated Urinary Tract Infections Shijina Koliyath, MBBS, MS 1 ; Ravi K. Chittoria, MS, MCh, DNB, MNAMS, PhD 2* ; Abhinav Aggarwal, MBBS, MS 2 ; Saurabh Gupta, MBBS, MS 1 ; Chirra L. Reddy, MBBS, DNB 1 ; Padmalakshmi B. Mohan, MBBS, MS 1 ; Imran Pathan, MBBS, MS 1 1 Department of Plastic Surgery, JIPMER, Pondicherry 605006, India 2 Department of Plastic Surgery and Telemedicine, JIPMER, Pondicherry 605006, India * Corresponding author Ravi Kumar Chittoria, MS, MCh, DNB, MNAMS, PhD Professor and Registrar, Head of IT Wing and Telemedicine, Department of Plastic Surgery and Telemedicine, JIPMER, Pondicherry 605006, India; Mobile. 9442285670; E-mail: drchittoria@yahoo.com Article information Received: September 23 rd , 2019; Revised: October 18 th , 2019; Accepted: October 22 nd , 2019; Published: October 24 th , 2019 Cite this article Shijina K, Chittoria RK, Aggarwal A, et al. Role of bactiguard infection technology in preventing catheter associated urinary tract infections. Clin Trial Pract Open J. 2019; 2(1): 19-21. doi: 10.17140/CTPOJ-2-108 Case Report Case Report | Volume 2 | Number 1 | 19 Copyright 2019 by Chittoria RK. This is an open-access article distributed under Creative Commons Attribution 4.0 International License (CC BY 4.0), which allows to copy, redistribute, remix, transform, and reproduce in any medium or format, even commercially, provided the original work is properly cited. cc ABSTRACT To study the role of bactiguard infection technology (BIP) in preventing Catheter-associated urinary tract infections. This study was conducted in a tertiary care centre in the Department of Plastic Surgery, JIPMER, Pondicherry, India in the month of August 2019. The study subject was a 55-year-old gentleman with Fournier’s gangrene and type 2 diabetes mellitus (DM). The Foley’s catheter with BIP technology was used and its role in preventing urinary tract infections (UTI) was studied over a period of 10-days. During the period of the catheter use in our subject, patient did not develop features of urinary tract infections. BIP technology is claimed to be effective in preventing Catheter-associated urinary tract infections but further studies in more individuals is required to validate the same. Keywords Bactiguard infection technology (BIP); Catheter associated urinary tract infection (CAUTI); Bioflm. INTRODUCTION H ealthcare-associated infections (HAIs) are a major concern in today’s era of medical advancement. According to World Health Organization (WHO), effective infection control and pre- vention can reduce HAIs by at least 30%. 1 HAIs are one of the leading causes of morbidity and mortality worldwide. Prolonged hospital stay, long-term disabilities, increased antibiotic resistance, increased fnancial burden are some of the implications of HAIs. Catheter-associated urinary tract infections (CAUTI) is the most common HAI and most of them are caused by indwelling urinary catheters. 2 CAUTI is almost always preceded by bacteriuria which develops with a frequency of 3-6% per day in a catheterised per- son. 3 Patients usually present with local and systemic symptoms of bacteriuria such as urgency, dysuria, abdominal pain and fever. The main causal agents of CAUTI are commensal perineal fo- ra. Most CAUTIs are monomicrobial commonly caused by E.coli, Pseudomonas aeruginosa, Enteroccocci, candida, klebsiella and enterobacter. 4 CAUTIs can lead to cystitis, pyelonephritis and bacteremia. Bac- teremia can in turn lead to septicaemia and septic shock which carries high mortality rate. Thus early prevention of CAUTI is of utmost important. High-risk individuals for acquiring CAUTI include those patients who require prolonged catheterisation and long hospital stay, patients with diabetes mellitus, Fournier’s gan- grene etc., Several urinary catheters have been specially designed to reduce the risk of infections and CAUTI. These include catheters with antiseptic and antimicrobial compounds such as silver ions, antibiotics and noble metal alloys. Here we describe our experience with the use of bactiguard infection protection (BIP) foley’s cathe- ter used in a patient with fournier’s gangrene. CASE REPORT This study was conducted in Department of Plastic Surgery, JIP- MER, Pondicherry, India in a tertiary care centre in the month of August 2019. Informed consent was taken from the partici- pant. A 16 Fr BIP Foley’s catheter (Latex) was used in a 55-year- old patient with Fournier’s gangrene and Type 2 diabetes mellitus